MaltSci 麦伴科研

Appearance

Popular Reports / metabolism

This report is written by MaltSci based on the latest literature and research findings

How does intermittent fasting affect metabolism? ​

Abstract ​

Intermittent fasting (IF) has gained considerable attention as a dietary strategy with potential health benefits, particularly in enhancing metabolic health amid rising rates of metabolic disorders like obesity and type 2 diabetes. This review examines the mechanisms through which IF influences metabolism, including hormonal changes, insulin sensitivity, and lipid metabolism. Key findings suggest that IF promotes a metabolic switch from glucose to fatty acid utilization, leading to improved fat metabolism and insulin sensitivity. Various IF regimens, such as time-restricted eating, alternate-day fasting, and the 5:2 diet, demonstrate unique metabolic impacts, including weight loss and favorable changes in metabolic markers. Clinical implications indicate that IF may benefit individuals with metabolic disorders by improving glucose tolerance, reducing inflammation, and enhancing overall metabolic profiles. However, challenges remain regarding the variability of individual responses to IF and the potential for adverse effects in certain populations. Future research should address these gaps by exploring long-term effects and optimizing fasting protocols tailored to individual needs. In conclusion, IF emerges as a viable strategy for enhancing metabolic health, warranting further investigation to fully realize its therapeutic potential.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Mechanisms of Intermittent Fasting on Metabolism
    • 2.1 Hormonal Changes Induced by Intermittent Fasting
    • 2.2 Effects on Insulin Sensitivity and Glucose Metabolism
    • 2.3 Influence on Lipid Metabolism and Fat Oxidation
  • 3 Types of Intermittent Fasting Regimens
    • 3.1 Time-Restricted Eating
    • 3.2 Alternate-Day Fasting
    • 3.3 5:2 Diet
  • 4 Clinical Implications of Intermittent Fasting
    • 4.1 Impact on Weight Loss and Body Composition
    • 4.2 Potential Benefits for Metabolic Disorders
    • 4.3 Considerations for Special Populations
  • 5 Current Research and Future Directions
    • 5.1 Gaps in Current Research
    • 5.2 Future Research Directions
    • 5.3 Practical Applications in Clinical Settings
  • 6 Conclusion

1 Introduction ​

Intermittent fasting (IF) has emerged as a prominent dietary strategy, capturing significant interest in both scientific research and popular culture due to its potential health benefits. This approach, characterized by alternating periods of fasting and eating, not only facilitates weight management but also promises to enhance metabolic health, particularly in the context of rising rates of metabolic disorders such as obesity and type 2 diabetes [1][2]. The current global health landscape, marked by an increasing prevalence of these conditions, necessitates innovative lifestyle interventions that can effectively improve metabolic profiles. IF represents a compelling area of investigation, offering insights into the mechanisms that underpin metabolic regulation and energy homeostasis [3].

The significance of understanding the effects of intermittent fasting on metabolism cannot be overstated. Recent studies have elucidated the multifaceted biological effects of IF, including its influence on metabolic switching from glucose to fatty acid utilization, which enhances fat metabolism and improves insulin sensitivity [1]. Additionally, IF has been shown to modulate key hormonal pathways, such as the growth hormone/insulin-like growth factor 1 (GH/IGF-1) axis, which is crucial for cellular protection and longevity [1]. As researchers delve deeper into the metabolic implications of various fasting regimens, it becomes increasingly evident that IF could serve as a valuable tool in the prevention and management of metabolic diseases [4].

Despite the promising findings surrounding intermittent fasting, the field remains rife with complexities and unanswered questions. The diversity of fasting protocols, such as time-restricted eating, alternate-day fasting, and the 5:2 diet, introduces variability in metabolic responses and health outcomes [2]. Furthermore, while many studies report beneficial effects on weight loss and metabolic markers, some highlight potential drawbacks, including the risk of adverse effects on hormonal balance and overall metabolic health [5][6]. Thus, a comprehensive examination of the current literature is essential to discern the nuanced effects of IF on metabolism and to identify optimal strategies for its application in clinical practice.

This review is organized into several key sections. First, we will explore the mechanisms through which intermittent fasting influences metabolic processes, focusing on hormonal changes, insulin sensitivity, and lipid metabolism [1][6]. Following this, we will categorize and discuss various types of intermittent fasting regimens, highlighting their unique characteristics and metabolic impacts [2]. The clinical implications of IF will then be addressed, with a focus on its effects on weight loss, body composition, and potential benefits for individuals with metabolic disorders [2][3]. Lastly, we will identify gaps in current research and propose future directions for investigation, emphasizing the importance of integrating dietary strategies with pharmacotherapy and lifestyle modifications to optimize metabolic health outcomes [5][7].

In conclusion, this review aims to provide a comprehensive overview of how intermittent fasting affects metabolism, offering insights that may inform both clinical practice and future research. By synthesizing existing literature and elucidating the underlying mechanisms, we hope to contribute to a deeper understanding of intermittent fasting as a viable strategy for enhancing metabolic health and preventing metabolic diseases.

2 Mechanisms of Intermittent Fasting on Metabolism ​

2.1 Hormonal Changes Induced by Intermittent Fasting ​

Intermittent fasting (IF) is increasingly recognized for its multifaceted effects on metabolism, particularly through hormonal regulation and the modulation of various metabolic pathways. The mechanisms by which IF influences metabolic health are complex and involve a variety of physiological changes.

One significant aspect of IF is its impact on hormonal circadian rhythms and endocrine function. Research indicates that IF can recalibrate hormonal rhythms, which are crucial for metabolic processes. For instance, it has been shown that IF can influence key hormones such as insulin, glucocorticoids, and sex hormones, potentially restoring homeostatic endocrine function [8]. Specifically, studies have demonstrated that IF can lower circulating insulin levels and enhance insulin sensitivity, thereby improving glucose metabolism [9].

The modulation of the growth hormone/insulin-like growth factor 1 (GH/IGF-1) axis is another critical mechanism through which IF affects metabolism. By reducing IGF-1 levels, IF may promote cellular protection, reduce tumorigenesis, and delay aging [1]. Furthermore, IF has been associated with the activation of stress-response pathways, autophagy, and improved mitochondrial function, which collectively contribute to enhanced metabolic flexibility [9].

Moreover, IF promotes a metabolic switch from glucose utilization to fatty acid and ketone body utilization. This switch occurs after approximately 12-16 hours of fasting, leading to increased fat oxidation and the mobilization of fatty acids, which can serve as an alternative energy source [10]. This shift not only aids in weight management but also enhances overall metabolic efficiency.

The gut microbiome also plays a pivotal role in the metabolic effects of IF. Studies have indicated that IF can alter the gut microbiota composition, which in turn influences metabolic pathways and circadian rhythms. The interaction between the gut microbiome and IF appears to enhance diurnal fluctuations in microbial activity, impacting the host's metabolic processes [11]. This suggests that the timing of food intake, a key component of IF, may significantly modulate metabolic health through gut microbiome dynamics.

In addition to these hormonal and microbial interactions, IF has been shown to affect inflammatory markers and oxidative stress levels, contributing to a reduction in metabolic inflammation. This anti-inflammatory effect is particularly beneficial for individuals with obesity and type 2 diabetes [6].

Overall, the hormonal changes induced by intermittent fasting encompass a range of metabolic adaptations, including improved insulin sensitivity, modulation of key endocrine pathways, and enhanced metabolic flexibility through shifts in energy substrate utilization. These mechanisms collectively position intermittent fasting as a promising strategy for optimizing metabolic health and potentially mitigating the risks associated with metabolic disorders. Further research is necessary to fully elucidate the long-term effects and clinical implications of IF on hormonal regulation and metabolic health.

2.2 Effects on Insulin Sensitivity and Glucose Metabolism ​

Intermittent fasting (IF) exerts significant effects on metabolism, particularly influencing insulin sensitivity and glucose metabolism through various mechanisms. The biological impacts of IF are multidimensional, primarily involving a metabolic switch from glucose utilization to fatty acid and ketone body utilization. This shift enhances fat metabolism while improving glucose tolerance and insulin sensitivity.

One of the key mechanisms by which IF affects metabolism is through the modulation of the growth hormone/insulin-like growth factor 1 (GH/IGF-1) axis. IF lowers IGF-1 levels, which is associated with enhanced cellular protection, reduced tumorigenesis, and delayed aging. Additionally, IF activates important signaling pathways, including the mitogen-activated protein kinases, Notch, and nuclear factor kappa B. These pathways collectively contribute to reduced oxidative stress, decreased inflammation, and hepatoprotection, which are crucial for maintaining metabolic health [1].

In animal studies, IF has been shown to significantly improve glucose metabolism and insulin sensitivity. For instance, in a study involving middle-aged mice fed a high-fat diet, IF led to reduced weight gain, decreased fat mass, and improved glucose tolerance and insulin sensitivity. The analysis of gut microbiota revealed a significant reduction in the Firmicutes/Bacteroidetes ratio, alongside changes in specific microbial populations that correlated with glucose metabolism-related indicators [12]. This indicates that IF not only directly impacts metabolic pathways but also alters the gut microbiome, which plays a critical role in metabolic regulation.

Furthermore, IF has been shown to enhance the body’s ability to respond to insulin. In a study assessing the effects of IF on healthy lean individuals, no significant differences were observed in whole-body glucose, lipid, or protein metabolism compared to a standard diet; however, the fasting regimen did not diminish peripheral glucose uptake or hepatic insulin sensitivity, suggesting a neutral effect on these parameters in this specific population [13].

Moreover, IF influences the activation of adenosine monophosphate-activated protein kinase (AMPK), which is essential for metabolic switching and improving insulin sensitivity. AMPK activation is associated with enhanced fatty acid oxidation and improved glucose uptake in tissues, thus contributing to better metabolic outcomes [14].

Intermittent fasting also appears to modulate circadian rhythms, which can affect hormone levels such as insulin and leptin, thereby influencing appetite and energy balance. This modulation can lead to improved metabolic profiles, particularly in individuals with metabolic syndrome and type 2 diabetes [9].

In summary, intermittent fasting affects metabolism through multiple mechanisms, including the induction of metabolic switching, modulation of hormonal axes, activation of key signaling pathways, and alterations in gut microbiota. These changes collectively enhance insulin sensitivity and glucose metabolism, suggesting that IF may serve as a beneficial strategy for managing metabolic health and related disorders. Further clinical studies are necessary to explore the long-term implications and efficacy of IF in various populations.

2.3 Influence on Lipid Metabolism and Fat Oxidation ​

Intermittent fasting (IF) exerts significant effects on metabolism, particularly influencing lipid metabolism and fat oxidation through various mechanisms. The activation of key signaling pathways, such as AMP-activated protein kinase (AMPK) and sirtuin 1 (SIRT1), plays a crucial role in mediating these metabolic adaptations. IF promotes fatty acid oxidation, enhances mitochondrial function, and facilitates metabolic health improvements, which are essential for preventing and treating various conditions, including neurodegenerative diseases and metabolic disorders [15].

One of the primary metabolic effects of IF is the induction of a metabolic switch from glucose to fatty acid and ketone utilization. This switch occurs after a period of fasting, where the depletion of liver glycogen stores leads to the mobilization of fatty acids from adipose tissue. As a result, fatty acid oxidation becomes the predominant energy source, which helps preserve muscle mass and function while optimizing energy utilization [10].

In animal studies, IF has been shown to enhance lipid utilization and promote mitochondrial activation in skeletal muscle. For instance, a study involving mice subjected to a specific fasting regimen (72 hours of fasting followed by 96 hours of ad libitum feeding) demonstrated significant upregulation of lipid oxidation genes, which was associated with histone hyperacetylation in the promoter regions of genes involved in lipid metabolism [16]. This metabolic remodeling not only improved fat oxidation but also sustained these effects even after the fasting period had ended.

Moreover, IF influences the levels of various hormones and plasma nonesterified fatty acids (NEFAs), which are critical for stimulating hepatic fatty acid oxidation and ketogenesis. The transcriptional regulation of these processes is primarily mediated by the peroxisome proliferator-activated receptor (PPAR)α, which coordinates the metabolic adaptations necessary during fasting [17].

The impact of IF on lipid metabolism is also evidenced by its effects on inflammatory markers and lipid profiles. For example, Ramadan intermittent fasting has been associated with improved levels of ceramides and sphingolipids, which are vital components of lipid metabolism. Such changes indicate a favorable shift in lipid profiles and suggest potential cardiometabolic protective effects in overweight and obese individuals [18].

Furthermore, IF has been shown to increase metabolic flexibility, particularly in lean individuals, allowing for better engagement of fatty acid metabolism. In contrast, studies have indicated that obese individuals may exhibit metabolic inflexibility, limiting the benefits of IF on lipid oxidation [19]. This discrepancy highlights the importance of metabolic context when considering the effects of fasting regimens.

Overall, the mechanisms through which intermittent fasting affects metabolism, particularly lipid metabolism and fat oxidation, are multifaceted. They involve the activation of critical metabolic pathways, hormonal changes, and alterations in gene expression, which collectively enhance the body's ability to utilize fat as an energy source and improve overall metabolic health [1].

3 Types of Intermittent Fasting Regimens ​

3.1 Time-Restricted Eating ​

Intermittent fasting (IF), particularly time-restricted eating (TRE), is characterized by the practice of consuming food within a specific time window each day, typically allowing for an extended fasting period. This dietary strategy has been shown to induce significant metabolic changes that can enhance metabolic health.

Time-restricted eating typically involves consuming all daily calories within a designated time frame, often 6 to 8 hours, followed by a fasting period of 16 to 18 hours. Such regimens have been associated with various metabolic benefits, including improved insulin sensitivity and glucose tolerance. Specifically, TRE has been linked to a decrease in fasting insulin levels and blood glucose levels, contributing to a lower risk of type 2 diabetes and improved overall metabolic health [20].

The physiological mechanisms underlying these benefits involve metabolic switching from glucose to fatty acid and ketone utilization during fasting periods. This metabolic shift enhances fat metabolism and promotes the use of stored fat as an energy source, which can lead to weight loss and improvements in body composition [1]. Additionally, intermittent fasting regimens like TRE have been found to modulate the growth hormone/insulin-like growth factor 1 (GH/IGF-1) axis, reducing IGF-1 levels associated with cellular protection and delayed aging [1].

Furthermore, TRE can positively influence circadian rhythms, which are crucial for metabolic regulation. Aligning eating patterns with the body's natural circadian cycles may enhance metabolic efficiency and support better energy balance [21]. This synchronization can help optimize hormone secretion and metabolic processes, potentially leading to sustained improvements in metabolic health [22].

In summary, time-restricted eating, as a form of intermittent fasting, promotes beneficial metabolic effects by inducing metabolic flexibility, enhancing fat oxidation, and improving insulin sensitivity. These changes contribute to weight management and may help mitigate the risks associated with metabolic diseases. However, further research is needed to fully elucidate the long-term effects and optimal protocols for implementing time-restricted eating effectively [23].

3.2 Alternate-Day Fasting ​

Intermittent fasting (IF), particularly through regimens such as alternate-day fasting (ADF), has garnered attention for its potential effects on metabolism. ADF involves alternating days of fasting (with limited caloric intake) and days of ad libitum eating. Research indicates that ADF can significantly influence various metabolic parameters.

A randomized controlled trial demonstrated that ADF over four weeks improved markers of general health in healthy, middle-aged individuals, achieving a 37% reduction in calorie intake on average without adverse effects even after six months. The study reported improvements in cardiovascular markers, reductions in fat mass (particularly trunk fat), and an increase in β-hydroxybutyrate levels, which is a ketone body that indicates enhanced fat metabolism [24]. Another study noted that ADF led to a decrease in body mass and fat mass, although the reductions in body fat were less pronounced compared to continuous daily energy restriction [25].

Metabolically, ADF has been shown to enhance fat metabolism and improve glucose tolerance and insulin sensitivity. It induces a metabolic switch from glucose to fatty acid and ketone utilization, which can be beneficial for weight management and metabolic health [1]. This switch not only aids in weight loss but also has implications for improving dyslipidemia and blood pressure [23].

Furthermore, ADF has been linked to decreased levels of systemic inflammation and improved metabolic flexibility, particularly in individuals with obesity or metabolic syndrome. It appears to lower metabolic inflammation and enhance glucose metabolism without necessarily reducing body weight, suggesting that ADF can have beneficial effects even in the absence of significant weight loss [6].

However, adherence to ADF can be challenging, and while it shows promise, the long-term effects and sustainability of this regimen require further investigation [26]. Overall, ADF represents a viable approach within the spectrum of intermittent fasting strategies that may yield favorable metabolic outcomes, particularly regarding fat loss and improvements in cardiometabolic health.

3.3 5:2 Diet ​

Intermittent fasting (IF) has garnered considerable attention for its potential metabolic benefits, particularly in the context of various regimens, including the 5:2 diet. The 5:2 diet involves normal eating for five days of the week and restricting caloric intake to about a quarter of the normal total daily caloric expenditure on two non-consecutive days. This dietary approach aims to induce metabolic changes that can enhance health outcomes.

Evidence indicates that the 5:2 intermittent fasting regimen can lead to significant weight loss and improvements in metabolic health markers. For instance, a randomized controlled trial assessing the effects of the 5:2 diet on patients with non-alcoholic fatty liver disease (NAFLD) reported that participants experienced reductions in body weight, body mass index (BMI), waist circumference, and fat mass, alongside improvements in liver enzymes and inflammatory markers [27]. Specifically, the study noted that body weight decreased from 86.65 kg to 82.94 kg, and alanine aminotransferase levels improved significantly from 41.42 U/L to 28.38 U/L, indicating a positive effect on liver health [27].

Furthermore, the 5:2 diet has been associated with favorable changes in cardiometabolic health. A review of intermittent fasting regimens, including the 5:2 diet, found that these dietary patterns resulted in mild to moderate weight loss (1-8% from baseline) and consistent reductions in energy intake (10-30% from baseline) [2]. Participants also exhibited reductions in blood pressure, insulin resistance, and oxidative stress, although findings regarding lipid levels varied [2].

In terms of metabolic flexibility, which refers to the body's ability to switch between fuel sources, intermittent fasting, including the 5:2 diet, has shown promise in promoting enhanced fat oxidation. A study demonstrated that a 5:2 regimen increased lipid oxidation in lean mice, suggesting potential benefits for metabolic flexibility [19]. However, this adaptation was not observed in obese type 2 diabetic mice, highlighting that the metabolic benefits of fasting may be contingent upon the individual's metabolic state [19].

Additionally, the 5:2 diet has been shown to impact glycemic control, particularly in individuals with type 2 diabetes. In a clinical trial, participants following the 5:2 meal replacement diet exhibited a significant reduction in hemoglobin A1c levels, surpassing the improvements seen with conventional medications like metformin and empagliflozin [28]. This underscores the potential of the 5:2 diet as an effective strategy for managing glycemic levels and improving metabolic health.

Moreover, the 5:2 diet's influence on inflammation and oxidative stress is noteworthy. Research indicates that intermittent fasting can lower metabolic inflammation and enhance glucose metabolism without necessitating weight loss [6]. This effect is particularly relevant in the context of obesity and metabolic disorders, where inflammation plays a significant role in disease progression.

In summary, the 5:2 intermittent fasting regimen offers a multifaceted approach to enhancing metabolic health. Through mechanisms such as weight loss, improved insulin sensitivity, and reduced inflammation, the 5:2 diet can contribute positively to metabolic outcomes. However, individual responses may vary based on baseline metabolic conditions, necessitating further research to fully elucidate the long-term effects and mechanisms underlying these benefits.

4 Clinical Implications of Intermittent Fasting ​

4.1 Impact on Weight Loss and Body Composition ​

Intermittent fasting (IF) has been extensively studied for its effects on metabolism, particularly in relation to weight loss and body composition. The findings from various studies indicate that IF can lead to significant reductions in body weight and improvements in several metabolic markers, particularly in individuals with prediabetes or type 2 diabetes (T2D).

A systematic review and meta-analysis by Khalafi et al. (2024) included 14 studies with a total of 1101 adults diagnosed with prediabetes or T2D. The results demonstrated that IF resulted in a mean decrease in body weight of 4.56 kg (95% CI -6.23 to -2.83; p = 0.001) and a reduction in body mass index (BMI) of 1.99 kg/m² (95% CI -2.74 to -1.23; p = 0.001). Additionally, significant reductions were observed in glycated hemoglobin (HbA1c; WMD -0.81% [95% CI -1.24 to -0.38]; p = 0.001), fasting glucose (WMD -0.36 mmol/L [95% CI -0.63 to -0.09]; p = 0.008), total cholesterol (WMD -0.31 mmol/L [95% CI -0.60 to -0.02]; p = 0.03), and triglycerides (WMD -0.14 mmol/L [95% CI -0.27 to -0.01]; p = 0.02). However, it was noted that IF did not significantly decrease fat mass, insulin levels, low-density lipoprotein (LDL), high-density lipoprotein (HDL), or blood pressure compared to control diets (Khalafi et al. 2024).

In a broader context, Tinsley and La Bounty (2015) reviewed various intermittent fasting protocols, including alternate-day fasting and time-restricted feeding, and found that these approaches generally led to a reduction in body weight ranging from approximately 3% to 9% and a decrease in body fat. The metabolic benefits were not limited to weight loss; there were also improvements in lipid profiles, with total cholesterol and triglycerides showing favorable reductions.

The narrative review by Gabel et al. (2025) further supports these findings, suggesting that the combination of intermittent fasting with exercise may enhance fat loss while promoting lean mass retention. They noted that intermittent fasting does not impair adaptation to exercise training and may improve cardiovascular fitness measures.

Moreover, Varady et al. (2021) summarized that various forms of intermittent fasting lead to mild to moderate weight loss (1-8% from baseline) and consistent reductions in energy intake (10-30% from baseline). These dietary patterns are associated with decreased blood pressure, improved insulin sensitivity, and reductions in oxidative stress, contributing to overall cardiometabolic health improvements.

Despite the promising outcomes associated with intermittent fasting, it is essential to note that individual responses can vary, and certain adverse effects, such as muscle loss or changes in hormonal levels, have been observed. For instance, Kim et al. (2021) indicated that intermittent fasting could decrease androgen markers, which may have implications for metabolic health.

In conclusion, intermittent fasting presents a viable strategy for enhancing metabolic health, particularly through weight loss and improvements in body composition and metabolic markers. However, it is crucial for individuals to consider personal health conditions and potential side effects when adopting such dietary strategies. Future research is needed to further elucidate the long-term effects of intermittent fasting and its integration with other lifestyle modifications for optimal health outcomes.

4.2 Potential Benefits for Metabolic Disorders ​

Intermittent fasting (IF) has emerged as a promising dietary strategy with significant implications for metabolic health, particularly in the management of metabolic disorders. The biological effects of intermittent fasting are multifaceted, involving a metabolic switch from glucose to fatty acid and ketone utilization, which enhances fat metabolism and improves glucose tolerance and insulin sensitivity. This metabolic switching is crucial as it promotes the use of fat as an energy source, thereby facilitating weight loss and improving overall metabolic function [1].

One of the key mechanisms through which intermittent fasting exerts its effects is by modulating the growth hormone/insulin-like growth factor 1 (GH/IGF-1) axis. IF has been shown to lower IGF-1 levels, a change associated with enhanced cellular protection, reduced tumorigenesis, and delayed aging [1]. Additionally, IF influences several critical signaling pathways, including mitogen-activated protein kinases, Notch, and nuclear factor kappa B, which collectively contribute to reduced oxidative stress, diminished inflammation, and hepatoprotection [1].

The implications of intermittent fasting for specific metabolic disorders, such as nonalcoholic fatty liver disease (NAFLD), are particularly noteworthy. Given the association between NAFLD and obesity, intermittent fasting has been hypothesized to offer benefits in managing this condition. The evidence suggests that intermittent fasting can reduce gut and systemic inflammation, improve gut microbial diversity, and enhance metabolic markers [29]. Although there is a lack of extensive clinical data specifically focusing on NAFLD, the potential mechanisms include modulation of circadian rhythms, adipose tissue dynamics, and autophagy [29].

Furthermore, intermittent fasting has been linked to improvements in cardiovascular health by enhancing insulin sensitivity and lipid profiles, thereby reducing the risk of obesity-related diseases such as type 2 diabetes [14]. The metabolic benefits of intermittent fasting extend beyond weight loss, as it also has the potential to support cardiovascular health and improve mental function [14].

Despite these potential benefits, it is crucial to recognize that the effects of intermittent fasting can vary significantly among individuals. Some may experience no clinical improvement, while others might face worsened outcomes due to pre-existing health conditions [14]. Therefore, the implementation of intermittent fasting should be personalized, taking into account individual health conditions and metabolic states [14].

In summary, intermittent fasting presents a viable approach to optimizing metabolic health, with mechanisms that enhance fat metabolism, improve insulin sensitivity, and reduce inflammation. However, careful consideration and further clinical studies are necessary to establish its efficacy and safety across diverse populations, particularly in those with specific metabolic disorders.

4.3 Considerations for Special Populations ​

Intermittent fasting (IF) has garnered attention for its potential effects on metabolism and overall health, but its clinical implications and effects on special populations warrant careful consideration.

Intermittent fasting encompasses various dietary patterns that alternate between periods of fasting and eating. It has been shown to induce metabolic switching from glucose metabolism to fatty acid and ketone utilization, which enhances fat metabolism and improves glucose tolerance and insulin sensitivity [1]. Additionally, IF has been associated with reductions in body weight, fasting insulin levels, and blood glucose levels, contributing to improved metabolic health [20]. Clinical trials have demonstrated that different IF regimens, such as alternate-day fasting (ADF) and time-restricted eating (TRE), can lead to weight loss (1-8% from baseline) and reductions in energy intake (10-30% from baseline), while also benefiting cardiometabolic health by decreasing blood pressure and insulin resistance [2].

However, the metabolic benefits of IF are not uniform across all demographics. Studies indicate that there may be sex-specific responses to IF, with potential disparities in body composition, glucose, and lipid metabolism between men and women [30]. This suggests that the implementation of IF should be tailored to individual characteristics, particularly considering age, sex, and underlying health conditions [14].

In special populations, such as adolescents, the implications of IF may differ significantly. Research indicates that IF may hinder the growth of pancreatic beta cells, adversely affecting insulin synthesis and increasing the risk of metabolic disorders in this age group [31]. Chronic IF in young mice has been shown to impair beta-cell maturation and function, suggesting that such dietary practices could exacerbate diabetes outcomes rather than mitigate them [32]. Therefore, the application of IF in adolescents should be approached with caution, and healthcare practitioners should prioritize balanced diets over uncontrolled fasting habits [31].

Moreover, while IF may confer benefits such as improved metabolic health, it is essential to recognize its potential adverse effects. For instance, some individuals may experience worsened outcomes or no clinical improvement from IF, emphasizing the need for personalized approaches to dietary interventions [14]. The adverse effects may also include increased risk of disordered eating patterns, particularly in vulnerable populations [31].

In summary, while intermittent fasting presents promising metabolic benefits and may serve as a therapeutic strategy for various conditions, its clinical implications necessitate careful consideration, particularly for special populations such as adolescents. Tailoring fasting protocols to individual needs and circumstances, alongside comprehensive clinical evaluation, will be crucial for maximizing the benefits of IF while minimizing potential risks. Further research is essential to establish optimal fasting protocols and to explore the long-term effects of IF across different demographic groups [14].

5 Current Research and Future Directions ​

5.1 Gaps in Current Research ​

Intermittent fasting (IF) has emerged as a prominent dietary strategy that can significantly influence metabolic health. Current research indicates that IF can enhance insulin sensitivity, reduce inflammation, and facilitate weight management, which collectively contribute to improved metabolic profiles. The underlying mechanisms of these effects are complex and involve metabolic switching from glucose to fatty acid utilization, which optimizes energy use and enhances fat metabolism [1].

One of the primary benefits of IF is its ability to improve metabolic health markers. Studies have shown that IF can lead to reductions in fasting insulin levels, blood glucose levels, and body weight [20]. Additionally, IF has been associated with favorable changes in lipid profiles, including reductions in low-density lipoprotein cholesterol and triglyceride levels, although findings can be variable [2]. The evidence also suggests that IF may enhance the diversity of the gut microbiome, which is critical for overall metabolic health [2].

However, the effects of IF on metabolism can vary significantly based on individual health conditions and the specific fasting regimen employed. For instance, while some individuals experience marked improvements in metabolic health, others may show little to no clinical improvement, and in some cases, even adverse effects [14]. This variability highlights the need for personalized approaches to IF, considering factors such as baseline metabolic state, underlying health conditions, and dietary composition [14].

Research also points to the potential for IF to influence hormonal circadian rhythms, which are crucial for maintaining metabolic homeostasis [22]. Disruptions in these rhythms can lead to detrimental effects on metabolic health, emphasizing the need for careful consideration of individual circumstances when implementing fasting protocols [22].

Future research directions should focus on addressing several gaps in the current understanding of IF and metabolism. These include the need for large-scale, long-term randomized controlled trials to ascertain the effectiveness of IF in regulating glucose homeostasis and its implications for metabolic diseases [33]. Furthermore, studies should explore the impact of different IF regimens on various populations, including those with specific metabolic disorders, to determine the most beneficial approaches [1].

In summary, while intermittent fasting shows promise as a strategy for enhancing metabolic health, ongoing research is essential to fully understand its effects, optimize protocols, and tailor interventions to individual needs. This will ensure that the potential benefits of IF can be realized without unintended negative consequences on metabolic and overall health.

5.2 Future Research Directions ​

Intermittent fasting (IF) has garnered significant attention in recent years for its potential effects on metabolism, influencing various physiological processes that can promote health and longevity. The metabolic impacts of intermittent fasting are multifaceted, primarily characterized by a metabolic switch from glucose to fatty acid utilization, which can enhance fat metabolism, improve insulin sensitivity, and promote overall metabolic health.

Research indicates that intermittent fasting can lead to a variety of metabolic improvements. For instance, it has been shown to optimize energy utilization by inducing a periodic switch from glucose metabolism to fatty acids and ketones, which may enhance physiological functions and slow aging processes (Strilbytska et al. 2024). This metabolic switching is associated with several beneficial effects, including improved glucose tolerance and reduced insulin resistance (Ciastek et al. 2025). Moreover, IF has been linked to reductions in body weight and fat mass, which are crucial for preventing obesity-related diseases (Varady et al. 2021).

Despite these positive findings, there is a growing recognition of the complexity of intermittent fasting's effects on metabolism, which can vary significantly based on individual health conditions and fasting protocols. For example, while some studies report that intermittent fasting can effectively improve metabolic health, others suggest that it may not be more effective than standard caloric restriction in the short term (Eliopoulos et al. 2025). Additionally, potential adverse effects have been identified, including the risk of cardiovascular disease mortality associated with long-term fasting regimens and concerns about lean mass loss and circadian misalignment (Eliopoulos et al. 2025).

Future research directions should focus on a few key areas to further elucidate the metabolic effects of intermittent fasting. First, there is a need for more extensive and long-term randomized controlled trials that assess the efficacy of various fasting protocols on metabolic health across diverse populations. These studies should consider individual factors such as baseline metabolic state, underlying health conditions, and genetic predispositions to tailor fasting regimens effectively (Zambuzzi et al. 2025). Additionally, investigations into the hormonal responses and circadian rhythms influenced by intermittent fasting are crucial, as they may reveal underlying mechanisms that contribute to both beneficial and adverse metabolic outcomes (Kim et al. 2021).

Furthermore, integrating intermittent fasting with other lifestyle interventions, such as exercise and pharmacotherapy for obesity, may enhance its benefits for metabolic health. Comprehensive approaches that combine dietary strategies with physical activity and personalized medicine could optimize outcomes for individuals struggling with obesity and metabolic disorders (Eliopoulos et al. 2025). Overall, continued research into the nuanced effects of intermittent fasting on metabolism will be essential for developing effective and safe dietary strategies that can promote health and prevent disease.

5.3 Practical Applications in Clinical Settings ​

Intermittent fasting (IF) has emerged as a significant dietary strategy with profound effects on metabolism, showcasing potential therapeutic benefits across various health conditions. Current research elucidates several mechanisms through which IF influences metabolic processes, providing a foundation for its application in clinical settings.

The primary metabolic impact of IF is the induction of a metabolic switch from glucose utilization to the oxidation of fatty acids and ketones. This switch enhances fat metabolism and improves insulin sensitivity, as demonstrated by Ciastek et al. (2025), who noted that IF activates several biological pathways, including the modulation of the growth hormone/insulin-like growth factor 1 (GH/IGF-1) axis, which is associated with enhanced cellular protection and reduced tumorigenesis [1]. Furthermore, IF has been shown to improve lipid profiles, reduce body weight, and increase insulin sensitivity, which are critical factors in managing obesity and related metabolic disorders [5].

Research indicates that various IF regimens, such as alternate-day fasting and time-restricted eating, lead to mild to moderate weight loss (1-8% from baseline) and consistent reductions in energy intake (10-30% from baseline) [2]. These regimens have been linked to decreased blood pressure, reduced insulin resistance, and lowered oxidative stress. Additionally, IF has shown potential in enhancing gut microbiome diversity, which may further support metabolic health [2].

The effects of IF, however, are not uniform across all individuals. Zambuzzi et al. (2025) highlight that while some patients exhibit improved metabolic health, others may experience no clinical improvement or even adverse outcomes [14]. This variability underscores the importance of personalizing IF protocols based on individual health conditions, metabolic states, and dietary compositions.

Moreover, while preclinical studies suggest that IF may confer benefits in conditions like cancer, rheumatoid arthritis, and neurodegenerative diseases, these findings require further validation through human studies [14]. For instance, IF has been associated with enhanced antitumor activity and improvements in neurological function, although the evidence remains limited [20].

Practical applications of IF in clinical settings necessitate a careful approach. Clinicians are encouraged to consider the individual characteristics of patients when recommending fasting protocols. The potential for adverse effects, particularly in specific populations such as adolescents, must also be taken into account. Research indicates that IF may impair pancreatic beta cell function in young individuals, leading to increased risks of metabolic disorders [31].

In summary, intermittent fasting holds promise as a therapeutic intervention for improving metabolic health, with a variety of mechanisms contributing to its effects. Future research should focus on optimizing fasting protocols, identifying the most effective regimens for different populations, and understanding the long-term implications of IF on metabolic and overall health. A comprehensive approach that integrates dietary strategies with pharmacotherapy and lifestyle modifications will be essential for maximizing the benefits of IF in clinical practice.

6 Conclusion ​

Intermittent fasting (IF) represents a promising dietary strategy with significant implications for enhancing metabolic health. The multifaceted biological effects of IF, particularly its ability to improve insulin sensitivity, reduce inflammation, and facilitate weight management, underscore its potential as a tool for preventing and managing metabolic disorders. Key findings indicate that IF induces a metabolic switch from glucose to fatty acid utilization, optimizing energy use and promoting fat metabolism. However, individual responses to IF can vary, necessitating personalized approaches to dietary interventions. Current research highlights the need for large-scale, long-term studies to further elucidate the complex effects of IF on metabolic health and to identify optimal fasting regimens for diverse populations. Future investigations should also focus on integrating IF with other lifestyle modifications, such as exercise and pharmacotherapy, to maximize its benefits for individuals with obesity and metabolic disorders. Overall, the continued exploration of IF's metabolic impacts will be essential for developing effective strategies to promote health and prevent disease.

References ​

  • [1] Barbara Ciastek;Karolina Kapłon;Przemysław Domaszewski. A Comprehensive Perspective on the Biological Effects of Intermittent Fasting and Periodic Short-Term Fasting: A Promising Strategy for Optimizing Metabolic Health.. Nutrients(IF=5.0). 2025. PMID:40647166. DOI: 10.3390/nu17132061.
  • [2] Krista A Varady;Sofia Cienfuegos;Mark Ezpeleta;Kelsey Gabel. Cardiometabolic Benefits of Intermittent Fasting.. Annual review of nutrition(IF=13.4). 2021. PMID:34633860. DOI: 10.1146/annurev-nutr-052020-041327.
  • [3] Ru-Xue Ma. A detective story of intermittent fasting effect on immunity.. Immunology(IF=5.0). 2024. PMID:38922825. DOI: 10.1111/imm.13829.
  • [4] Olha Strilbytska;Svitlana Klishch;Kenneth B Storey;Alexander Koliada;Oleh Lushchak. Intermittent fasting and longevity: From animal models to implication for humans.. Ageing research reviews(IF=12.4). 2024. PMID:38499159. DOI: 10.1016/j.arr.2024.102274.
  • [5] Aristides G Eliopoulos;Kalliopi K Gkouskou;Konstantinos Tsioufis;Despina Sanoudou. A perspective on intermittent fasting and cardiovascular risk in the era of obesity pharmacotherapy.. Frontiers in nutrition(IF=5.1). 2025. PMID:39895836. DOI: 10.3389/fnut.2025.1524125.
  • [6] Daniel M Marko;Meghan O Conn;Jonathan D Schertzer. Intermittent fasting influences immunity and metabolism.. Trends in endocrinology and metabolism: TEM(IF=12.6). 2024. PMID:38719726. DOI: 10.1016/j.tem.2024.04.014.
  • [7] Rami Al-Jafar;Wang Yuqi;Paul Elliott;Konstantinos K Tsilidis;Abbas Dehghan. The dietary changes during Ramadan and their impact on anthropometry, blood pressure, and metabolic profile.. Frontiers in nutrition(IF=5.1). 2024. PMID:38915859. DOI: 10.3389/fnut.2024.1394673.
  • [8] Wijdan Shkorfu;Abdulmannan Fadel;Mohammed Hamsho;Yazan Ranneh;Hafiz Muhammad Shahbaz. Intermittent Fasting and Hormonal Regulation: Pathways to Improved Metabolic Health.. Food science & nutrition(IF=3.8). 2025. PMID:40777199. DOI: 10.1002/fsn3.70586.
  • [9] Lisandra Joaquim;Ana Faria;Helena Loureiro;Paulo Matafome. Benefits, mechanisms, and risks of intermittent fasting in metabolic syndrome and type 2 diabetes.. Journal of physiology and biochemistry(IF=4.3). 2022. PMID:34985730. DOI: 10.1007/s13105-021-00839-4.
  • [10] Stephen D Anton;Keelin Moehl;William T Donahoo;Krisztina Marosi;Stephanie A Lee;Arch G Mainous;Christiaan Leeuwenburgh;Mark P Mattson. Flipping the Metabolic Switch: Understanding and Applying the Health Benefits of Fasting.. Obesity (Silver Spring, Md.)(IF=4.7). 2018. PMID:29086496. DOI: 10.1002/oby.22065.
  • [11] M C Daas;N M de Roos. Intermittent fasting contributes to aligned circadian rhythms through interactions with the gut microbiome.. Beneficial microbes(IF=3.1). 2021. PMID:33530881. DOI: 10.3920/BM2020.0149.
  • [12] Ziru Li;Sufang Chen;Bingbing Yin;Jiacun Wei;Duofei Wang;Huoxiang Zhou;Zhi Sun. Intermittent fasting regulates gut microbiota and serum metabolome profiles in middle-aged mice fed high-fat diet.. Nutrition & metabolism(IF=4.1). 2025. PMID:40001132. DOI: 10.1186/s12986-025-00904-5.
  • [13] Maarten R Soeters;Nicolette M Lammers;Peter F Dubbelhuis;Mariëtte Ackermans;Cora F Jonkers-Schuitema;Eric Fliers;Hans P Sauerwein;Johannes M Aerts;Mireille J Serlie. Intermittent fasting does not affect whole-body glucose, lipid, or protein metabolism.. The American journal of clinical nutrition(IF=6.9). 2009. PMID:19776143. DOI: 10.3945/ajcn.2008.27327.
  • [14] Willian F Zambuzzi;Marcel Rodrigues Ferreira;Zifan Wang;Maikel P Peppelenbosch. A Biochemical View on Intermittent Fasting's Effects on Human Physiology-Not Always a Beneficial Strategy.. Biology(IF=3.5). 2025. PMID:40563920. DOI: 10.3390/biology14060669.
  • [15] Anren Zhang;Junyu Wang;Yinuo Zhao;Yu He;Nianyi Sun. Intermittent fasting, fatty acid metabolism reprogramming, and neuroimmuno microenvironment: mechanisms and application prospects.. Frontiers in nutrition(IF=5.1). 2024. PMID:39512520. DOI: 10.3389/fnut.2024.1485632.
  • [16] Sho Endo;Asuka Uto;Kazutoshi Miyashita;Masaaki Sato;Hiroyuki Inoue;Kentaro Fujii;Aika Hagiwara;Masaki Ryuzaki;Takuma Oshida;Kenichiro Kinouchi;Hiroshi Itoh. Intermittent Fasting Sustainably Improves Glucose Tolerance in Normal Weight Male Mice Through Histone Hyperacetylation.. Journal of the Endocrine Society(IF=3.1). 2023. PMID:37362383. DOI: 10.1210/jendso/bvad082.
  • [17] Philip M M Ruppert;Sander Kersten. Mechanisms of hepatic fatty acid oxidation and ketogenesis during fasting.. Trends in endocrinology and metabolism: TEM(IF=12.6). 2024. PMID:37940485. DOI: 10.1016/j.tem.2023.10.002.
  • [18] Mohamed Ibrahim Madkour;Md Torikul Islam;Trevor S Tippetts;Kamrul H Chowdhury;Lisa A Lesniewski;Scott A Summers;Falak Zeb;Dana N Abdelrahim;Refat AlKurd;Husam M Khraiwesh;Katia H AbuShihab;Asma AlBakri;Khaled Obaideen;MoezAlIslam E Faris. Ramadan intermittent fasting is associated with ameliorated inflammatory markers and improved plasma sphingolipids/ceramides in subjects with obesity: lipidomics analysis.. Scientific reports(IF=3.9). 2023. PMID:37833312. DOI: 10.1038/s41598-023-43862-9.
  • [19] Meghan O Conn;Daniel M Marko;Jonathan D Schertzer. Intermittent fasting increases fat oxidation and promotes metabolic flexibility in lean mice but not obese type 2 diabetic mice.. American journal of physiology. Endocrinology and metabolism(IF=3.1). 2024. PMID:39196802. DOI: 10.1152/ajpendo.00255.2024.
  • [20] Simin Liu;Min Zeng;Weixi Wan;Ming Huang;Xiang Li;Zixian Xie;Shang Wang;Yu Cai. The Health-Promoting Effects and the Mechanism of Intermittent Fasting.. Journal of diabetes research(IF=3.4). 2023. PMID:36911497. DOI: 10.1155/2023/4038546.
  • [21] Ruth E Patterson;Dorothy D Sears. Metabolic Effects of Intermittent Fasting.. Annual review of nutrition(IF=13.4). 2017. PMID:28715993. DOI: 10.1146/annurev-nutr-071816-064634.
  • [22] Bo Hye Kim;Yena Joo;Min-Seon Kim;Han Kyoung Choe;Qingchun Tong;Obin Kwon. Effects of Intermittent Fasting on the Circulating Levels and Circadian Rhythms of Hormones.. Endocrinology and metabolism (Seoul, Korea)(IF=4.2). 2021. PMID:34474513. DOI: 10.3803/EnM.2021.405.
  • [23] Izzah Vasim;Chaudry N Majeed;Mark D DeBoer. Intermittent Fasting and Metabolic Health.. Nutrients(IF=5.0). 2022. PMID:35276989. DOI: 10.3390/nu14030631.
  • [24] Slaven Stekovic;Sebastian J Hofer;Norbert Tripolt;Miguel A Aon;Philipp Royer;Lukas Pein;Julia T Stadler;Tobias Pendl;Barbara Prietl;Jasmin Url;Sabrina Schroeder;Jelena Tadic;Tobias Eisenberg;Christoph Magnes;Michael Stumpe;Elmar Zuegner;Natalie Bordag;Regina Riedl;Albrecht Schmidt;Ewald Kolesnik;Nicolas Verheyen;Anna Springer;Tobias Madl;Frank Sinner;Rafael de Cabo;Guido Kroemer;Barbara Obermayer-Pietsch;Jörn Dengjel;Harald Sourij;Thomas R Pieber;Frank Madeo. Alternate Day Fasting Improves Physiological and Molecular Markers of Aging in Healthy, Non-obese Humans.. Cell metabolism(IF=30.9). 2019. PMID:31471173. DOI: 10.1016/j.cmet.2019.07.016.
  • [25] Iain Templeman;Harry Alex Smith;Enhad Chowdhury;Yung-Chih Chen;Harriet Carroll;Drusus Johnson-Bonson;Aaron Hengist;Rowan Smith;Jade Creighton;David Clayton;Ian Varley;Leonidas Georgios Karagounis;Andrew Wilhelmsen;Kostas Tsintzas;Sue Reeves;Jean-Philippe Walhin;Javier Thomas Gonzalez;Dylan Thompson;James Alexander Betts. A randomized controlled trial to isolate the effects of fasting and energy restriction on weight loss and metabolic health in lean adults.. Science translational medicine(IF=14.6). 2021. PMID:34135111. DOI: 10.1126/scitranslmed.abd8034.
  • [26] Daniel Herz;Sebastian Karl;Johannes Weiß;Paul Zimmermann;Sandra Haupt;Rebecca Tanja Zimmer;Janis Schierbauer;Nadine Bianca Wachsmuth;Maximilian Paul Erlmann;Tobias Niedrist;Kayvan Khoramipour;Thomas Voit;Sian Rilstone;Harald Sourij;Othmar Moser. Effects of Different Types of Intermittent Fasting Interventions on Metabolic Health in Healthy Individuals (EDIF): A Randomised Trial with a Controlled-Run in Phase.. Nutrients(IF=5.0). 2024. PMID:38674802. DOI: 10.3390/nu16081114.
  • [27] Hamed Kord Varkaneh;Ammar Salehi Sahlabadi;Mihnea-Alexandru Găman;Mohsen Rajabnia;Melahat Sedanur Macit-Çelebi;Heitor O Santos;Azita Hekmatdoost. Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial.. Frontiers in nutrition(IF=5.1). 2022. PMID:35958257. DOI: 10.3389/fnut.2022.948655.
  • [28] Lixin Guo;Yue Xi;Wenbo Jin;Huijuan Yuan;Guijun Qin;Shuchun Chen;Lihui Zhang;Yu Liu;Xingbo Cheng;Wen Liu;Dongni Yu. A 5:2 Intermittent Fasting Meal Replacement Diet and Glycemic Control for Adults With Diabetes: The EARLY Randomized Clinical Trial.. JAMA network open(IF=9.7). 2024. PMID:38904963. DOI: 10.1001/jamanetworkopen.2024.16786.
  • [29] Celeste M Lavallee;Andreina Bruno;Christopher Ma;Maitreyi Raman. The Role of Intermittent Fasting in the Management of Nonalcoholic Fatty Liver Disease: A Narrative Review.. Nutrients(IF=5.0). 2022. PMID:36364915. DOI: 10.3390/nu14214655.
  • [30] Julia Rius-Bonet;Salvador Macip;Daniel Closa;Marta Massip-Salcedo. Intermittent fasting as a dietary intervention with potential sexually dimorphic health benefits.. Nutrition reviews(IF=4.9). 2025. PMID:38812084. DOI: 10.1093/nutrit/nuae062.
  • [31] Dinesh Kumar;Vrinda Gupta;Rajni Tanwar;Vikas Bansal. Unveiling the Hidden Dangers of Intermittent Fasting in Adolescents: A Call for Awareness.. Journal of gastroenterology and hepatology(IF=3.4). 2025. PMID:40936230. DOI: 10.1111/jgh.70077.
  • [32] Leonardo Matta;Peter Weber;Suheda Erener;Alina Walth-Hummel;Daniela Hass;Lea K Bühler;Katarina Klepac;Julia Szendroedi;Joel Guerra;Maria Rohm;Michael Sterr;Heiko Lickert;Alexander Bartelt;Stephan Herzig. Chronic intermittent fasting impairs β cell maturation and function in adolescent mice.. Cell reports(IF=6.9). 2025. PMID:39827461. DOI: 10.1016/j.celrep.2024.115225.
  • [33] Krista A Varady. Impact of intermittent fasting on glucose homeostasis.. Current opinion in clinical nutrition and metabolic care(IF=3.5). 2016. PMID:27137896. DOI: 10.1097/MCO.0000000000000291.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Intermittent Fasting · Metabolic Health · Insulin Sensitivity · Lipid Metabolism · Weight Management

© 2025 MaltSci